Bu Shang Pharmaceutical: Shanghai Hepu plans to invest 4.9 million yuan to establish two new companies.

Boai Pharmaceutical announced that its holding subsidiary, Shanghai Hepu Medical Technology Co., Ltd., plans to invest a total of 4.9 million yuan in external investments. They will jointly invest with Jinan Hengde Technology Development Co., Ltd. and Shanghai Guoding Technology Co., Ltd. to establish two new companies. Shandong Hepu Ruicheng Medical Technology Co., Ltd. has a registered capital of 4 million yuan, with Shanghai Hepu investing 2.8 million yuan, holding a 70% stake; Jinan Hengde Technology investing 1.2 million yuan, holding a 30% stake. Hubei Hepu Medical Technology Co., Ltd. has a registered capital of 3 million yuan, with Shanghai Hepu investing 2.1 million yuan, holding a 70% stake; Shanghai Guoding Technology investing 900,000 yuan, holding a 30% stake. This transaction does not meet the standard for shareholder meeting approval and does not require submission for shareholder meeting approval.